全文获取类型
收费全文 | 3959篇 |
免费 | 339篇 |
国内免费 | 18篇 |
专业分类
耳鼻咽喉 | 29篇 |
儿科学 | 185篇 |
妇产科学 | 128篇 |
基础医学 | 637篇 |
口腔科学 | 120篇 |
临床医学 | 431篇 |
内科学 | 802篇 |
皮肤病学 | 68篇 |
神经病学 | 239篇 |
特种医学 | 122篇 |
外科学 | 503篇 |
综合类 | 103篇 |
一般理论 | 4篇 |
预防医学 | 418篇 |
眼科学 | 38篇 |
药学 | 279篇 |
中国医学 | 9篇 |
肿瘤学 | 201篇 |
出版年
2023年 | 20篇 |
2022年 | 40篇 |
2021年 | 100篇 |
2020年 | 55篇 |
2019年 | 75篇 |
2018年 | 94篇 |
2017年 | 57篇 |
2016年 | 76篇 |
2015年 | 76篇 |
2014年 | 96篇 |
2013年 | 152篇 |
2012年 | 225篇 |
2011年 | 246篇 |
2010年 | 129篇 |
2009年 | 145篇 |
2008年 | 203篇 |
2007年 | 209篇 |
2006年 | 206篇 |
2005年 | 226篇 |
2004年 | 165篇 |
2003年 | 173篇 |
2002年 | 160篇 |
2001年 | 88篇 |
2000年 | 94篇 |
1999年 | 90篇 |
1998年 | 48篇 |
1997年 | 29篇 |
1996年 | 34篇 |
1995年 | 42篇 |
1993年 | 31篇 |
1992年 | 72篇 |
1991年 | 65篇 |
1990年 | 51篇 |
1989年 | 64篇 |
1988年 | 57篇 |
1987年 | 42篇 |
1986年 | 52篇 |
1985年 | 46篇 |
1984年 | 35篇 |
1983年 | 28篇 |
1981年 | 24篇 |
1980年 | 23篇 |
1979年 | 21篇 |
1978年 | 24篇 |
1976年 | 17篇 |
1974年 | 20篇 |
1973年 | 20篇 |
1972年 | 18篇 |
1970年 | 26篇 |
1966年 | 22篇 |
排序方式: 共有4316条查询结果,搜索用时 9 毫秒
21.
The CAMPATH-1 (CDw52) antigen has been purified from human spleen. The antigenic epitope is heat stable but sensitive to mild alkali treatment. Experiments with phosphatidylinositol-specific phospholipase C indicate that it is anchored by a glycosylphosphatidylinositol (GPI) anchor. An N-terminal sequence of 11 amino acids was determined, followed by an abrupt stop. Using short overlapping mixed oligonucleotide primers, cDNA synthesized from the mRNA of a human B cell line was amplified by the polymerase chain reaction. The product was used to isolate cDNA clones and the full amino acid sequence of the CAMPATH-1 antigen was deduced. It consists of 37 amino acid residues plus a 24-residue signal peptide. It has all the features expected for a GPI-anchored membrane protein except that the predicted mature protein is remarkably short, comprising no more than 18 residues and possibly as few as 12 (depending on the GPI linkage site). Potential attachment sites for carbohydrate are present and it is shown that the antigen contains N-linked oligosaccharide(s). This structure accounts for the known properties of the antigen, though the exact reasons why it is such a good target for cell lysis in vitro and in vivo are not yet clear. 相似文献
22.
Rena K. Fox 《Current hepatitis reports》2003,2(3):116-124
Observational and some experimental data suggest that hepatitis C virus can manifest in a variety of disease processes outside
the liver. The links between hepatitis C virus and membranoproliferative glomerulonephropathy, porphyria cutanea tarda, lichen
planus, cryoglobulinemia, diabetes mellitus, B-cell non-Hodgkin’s lymphoma, and thyroiditis are critically reviewed. Based
on the available evidence, recommendations for the clinical approach to patients with extrahepatic diseases are discussed. 相似文献
23.
24.
Campath-1M--prophylactic use after kidney transplantation. A randomized controlled clinical trial 总被引:3,自引:0,他引:3
P J Friend G Hale H Waldmann S Gore S Thiru V Joysey D B Evans R Y Calne 《Transplantation》1989,48(2):248-253
Campath-1M is a rat monoclonal IgM antibody that binds human complement and recognizes virtually all peripheral human mononuclear cells. It is known to be effective in T cell depletion of bone marrow grafts, and encouraging results were obtained in a pilot study in which the antibody was used in prevention and treatment of rejection of kidney, pancreas, and liver allografts. In this randomized controlled clinical trial, Campath-1M has been evaluated as a prophylactic agent following renal allografting. It is shown that patients who received a 10-day course of the antibody immediately postoperatively, in addition to standard therapy with high-dose cyclosporine (17 mg/kg), experienced a significantly lower incidence of early acute cellular rejection than control patients who received cyclosporine alone. There was no evidence of "rebound" rejection following the end of antibody treatment to suggest that rejection had merely been delayed. However, patients who received this additional immunosuppression experienced a significantly higher incidence of serious infections than controls, this negating any benefit from the treatment in terms of graft survival. Thus, a monoclonal antibody of broad specificity directed against lymphocytes may be effective as a prophylactic agent after organ transplantation but its use should be accompanied by a reduction in other immunosuppressive drugs. 相似文献
25.
Gregory A Hale Laura C Bowman Richard J Rochester Eli Benaim Helen E Heslop Robert A Krance Edwin M Horwitz John M Cunningham Xin Tong Deo Kumar Srivastava Rupert Handgretinger Deborah P Jones 《Biology of blood and marrow transplantation》2005,11(11):912-920
Hemolytic uremic syndrome (HUS) is an uncommon but potentially life-threatening complication of hematopoietic stem cell transplantation. We retrospectively studied the medical records of 293 children who underwent allogeneic bone marrow transplantation at St. Jude Children's Research Hospital between 1992 and 1999 to describe the clinical course of and to identify risk factors for transplant-associated HUS. Conditioning regimens included cyclophosphamide, cytarabine, and total body irradiation for patients with hematologic malignancies (n = 244); patients with nonmalignant diseases (n = 49) received disease-specific regimens. Grafts from unrelated or mismatched related donors were depleted of T lymphocytes, whereas matched sibling grafts were unmanipulated. All patients received cyclosporine as prophylaxis for graft-versus-host disease. Recipients of grafts from matched siblings also received pentoxifylline or short-course methotrexate. HUS developed in 28 (9.6%) patients at a median of 171 days after transplantation. We identified older donor age (P = .029), use of antithymocyte globulin in the conditioning regimen (P = .008), and recipient CMV seronegativity (P = .011) as being associated with an increased risk of HUS. With a multiple regression analysis, the use of antithymocyte globulin (beta = .86; P = .04) and recipient cytomegalovirus seronegativity (beta = .93; P = .035) remained significant risk factors for the development of HUS. 相似文献
26.
Casas KA Mononen TK Mikail CN Hassed SJ Li S Mulvihill JJ Lin HJ Falk RE 《American journal of medical genetics. Part A》2004,(4):331-339
We report a new patient with terminal deletion of chromosome 2 with breakpoint at 2q36 and five additional new patients with 2q terminal deletion with breakpoint at 2q37. Hemidiaphragmatic hernia is a novel finding in one patient with a breakpoint at 2q37.1. In comparing these patients to 60 previously reported individuals with 2q terminal deletions, certain physical abnormalities are loosely associated with positions of breakpoint. For example, facial features (e.g., prominent forehead, depressed nasal bridge, and dysmorphic ears and nose), short stature, and short hands and feet were frequent in patients with breakpoints at or proximal to 2q37.3. Reports of horseshoe kidney and Wilms tumor were limited to patients with a breakpoint at 2q37.1, and structural brain anomalies and tracheal anomalies were reported only in patients with breakpoints at or proximal to 2q37.1. Cleft palate was reported only in patients with the most proximal breakpoints (2q36 or 2q35). Neurological effects including developmental delay, mental retardation, autistic-like behavior, and hypotonia were typical in this patient population but did not stratify in severity according to breakpoint. Terminal deletion of the long arm of chromosome 2 should be considered in the infant with marked hypotonia, poor feeding, gastroesophageal reflux, and growth delay, and the older child with developmental delay, autistic behavior, and the characteristic facial and integumentary features described herein. Assignment of clinical features to specific breakpoints and refinement of predictive value may be useful in counseling. 相似文献
27.
K. M. Mitchell R. J. Hale C. H. Buckley H. Fox D. Smith 《Virchows Archiv : an international journal of pathology》1993,422(5):357-360
An immunohistochemical study was made of cathepsin-D protein expression in each of the three main types of uterine cervical carcinoma (squamous carcinoma, adenosquamous carcinoma and adenocarcinoma) with particular reference to lymph node status and prognosis. Of the 61 cases, 54.1% showed cytoplasmic staining in more than 2.5% of tumour cells counted. Cathepsin-D expression was significantly higher in adenocarcinoma (mean -3.128) than in squamous carcinoma and adenosquamous carcinoma (mean –3.709,P=0.047 using logit transformation). Cathepsin-D had no prognostic value in any of the three tumour types. No relationship was found between cathepsin-D staining and lymph node status and there was no advantage in adding cathepsin-D values to lymph node status. These results suggest that immunostaining for cathepsin-D protein expression is unlikely to be of use as a prognostic marker. 相似文献
28.
Guiying Nie Kathryn Hale Ying Li Ursula Manuelpillai Euan M Wallace Lois A Salamonsen 《Developmental dynamics》2006,235(12):3448-3455
Mammalian embryos cannot survive without the placenta. Development of the human placenta requires trophoblast proliferation, differentiation, and invasion as well as highly coordinated modulation of the maternal uterus. HtrA1 is a member of the recently identified mammalian HtrA (high temperature requirement factor A) serine protease family with a high level of expression in the placenta. In this study, we examined whether HtrA1 expression (mRNA and protein) is associated with placental development in the human. HtrA1 is up-regulated in both endometrial glands and decidual cells during endometrial preparation for embryo implantation and during first-trimester pregnancy at placentation. HtrA1 expression was also detected in certain trophoblast subtypes during early pregnancy. The villous syncytiotrophoblast and cytotrophoblast showed the strongest expression while the interstitial extravillous trophoblast showed the lowest or no expression of HtrA1. The distinct distribution of HtrA1 at the maternal-trophoblast interface suggests that HtrA1 may play a role in placental development. 相似文献
29.
30.
Rapid identification by the Micro-ID system of Enterobacteriaceae detected by urine screening. 总被引:1,自引:2,他引:1 下载免费PDF全文
Previous studies have demonstrated that organisms detected by urine screening can be processed for rapid identification and antimicrobial susceptibility testing directly from urine or urine screening broth. In the present study, an improved method for processing such specimens was evaluated. Organisms were harvested by centrifugation from positive urine screening broth, and inocula were prepared for rapid identification by the Micro-ID system and rapid susceptibility testing by the Autobac system. Nearly 2,500 urine specimens were analyzed by urine screening, and 206 specimens had significant growth of gram-negative, oxidase-negative bacilli. These organisms, prepared by the centrifugation procedure, were identified and tested for susceptibility to antimicrobial agents. For comparison, identifications by the Micro-ID system and antimicrobial susceptibility tests by the Autobac system were performed on the same organisms the next day with inocula prepared from colonies growing from standard urine cultures. The results demonstrated that 95% of the organisms were correctly identified by this procedure, and susceptibility testing by the rapid method gave results in 94% agreement with the standard method. These results demonstrate that organisms detected by urine screening can be accurately identified and tested for antimicrobial susceptibility after centrifugation from urine screening broth. This system provides a practical procedure or same-day reporting of urine culture results. 相似文献